190 related articles for article (PubMed ID: 17804747)
1. Radiosensitization and modulation of p44/42 mitogen-activated protein kinase by 2-Methoxyestradiol in prostate cancer models.
Casarez EV; Dunlap-Brown ME; Conaway MR; Amorino GP
Cancer Res; 2007 Sep; 67(17):8316-24. PubMed ID: 17804747
[TBL] [Abstract][Full Text] [Related]
2. p38 Mitogen-activated protein kinases is required for counteraction of 2-methoxyestradiol to estradiol-stimulated cell proliferation and induction of apoptosis in ovarian carcinoma cells via phosphorylation Bcl-2.
Bu SZ; Huang Q; Jiang YM; Min HB; Hou Y; Guo ZY; Wei JF; Wang JW; Ni X; Zheng SS
Apoptosis; 2006 Mar; 11(3):413-25. PubMed ID: 16538384
[TBL] [Abstract][Full Text] [Related]
3. CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.
Chen Y; DeWeese T; Dilley J; Zhang Y; Li Y; Ramesh N; Lee J; Pennathur-Das R; Radzyminski J; Wypych J; Brignetti D; Scott S; Stephens J; Karpf DB; Henderson DR; Yu DC
Cancer Res; 2001 Jul; 61(14):5453-60. PubMed ID: 11454691
[TBL] [Abstract][Full Text] [Related]
4. Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328.
Steiner H; Cavarretta IT; Moser PL; Berger AP; Bektic J; Dietrich H; Zaki MH; Nakada M; Hobisch A; Nemeth JA; Culig Z
Prostate; 2006 Dec; 66(16):1744-52. PubMed ID: 16998813
[TBL] [Abstract][Full Text] [Related]
5. Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma.
Hagan M; Yacoub A; Dent P
Clin Cancer Res; 2004 Sep; 10(17):5724-31. PubMed ID: 15355899
[TBL] [Abstract][Full Text] [Related]
6. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS
J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
[TBL] [Abstract][Full Text] [Related]
8. p42/p44 Mitogen-activated protein kinase signal transduction pathway regulates interleukin-6 expression in PC3 cells, a line of hormone-refractory prostate cancer cells.
Koul S; Huang M; Chaturvedi L; Meacham RB; Koul HK
Ann N Y Acad Sci; 2004 Dec; 1030():253-7. PubMed ID: 15659804
[TBL] [Abstract][Full Text] [Related]
9. Low dose combinations of 2-methoxyestradiol and docetaxel block prostate cancer cells in mitosis and increase apoptosis.
Reiner T; de las Pozas A; Gomez LA; Perez-Stable C
Cancer Lett; 2009 Apr; 276(1):21-31. PubMed ID: 19046802
[TBL] [Abstract][Full Text] [Related]
10. Imaging mitogen-activated protein kinase function in xenograft models of prostate cancer.
Ilagan R; Pottratz J; Le K; Zhang L; Wong SG; Ayala R; Iyer M; Wu L; Gambhir SS; Carey M
Cancer Res; 2006 Nov; 66(22):10778-85. PubMed ID: 17108114
[TBL] [Abstract][Full Text] [Related]
11. Radiation sensitizing effect of estramustine is not dependent on apoptosis.
Ståhlberg K; Kairemo K; Erkkilä K; Pentikäinen V; Sorvari P; Taari K; Dunkel L; Rannikko S
Anticancer Res; 2005; 25(4):2873-8. PubMed ID: 16080540
[TBL] [Abstract][Full Text] [Related]
12. 2-Methoxyestradiol inhibits prostate tumor development in transgenic adenocarcinoma of mouse prostate: role of tumor necrosis factor-alpha-stimulated gene 6.
Garcia GE; Wisniewski HG; Lucia MS; Arevalo N; Slaga TJ; Kraft SL; Strange R; Kumar AP
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):980-8. PubMed ID: 16467113
[TBL] [Abstract][Full Text] [Related]
13. Novel 2-methoxyestradiol analogues with antitumor activity.
Tinley TL; Leal RM; Randall-Hlubek DA; Cessac JW; Wilkens LR; Rao PN; Mooberry SL
Cancer Res; 2003 Apr; 63(7):1538-49. PubMed ID: 12670902
[TBL] [Abstract][Full Text] [Related]
14. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma.
Dingli D; Timm M; Russell SJ; Witzig TE; Rajkumar SV
Clin Cancer Res; 2002 Dec; 8(12):3948-54. PubMed ID: 12473611
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human prostate cancer xenograft growth by 125I labeled triple-helix forming oligonucleotide directed against androgen receptor.
Zhang Y; Ma Y; Lu HP; Gao JH; Liang CS; Liu CZ; Zou JT; Wang HQ
Chin Med J (Engl); 2008 Nov; 121(22):2284-9. PubMed ID: 19080333
[TBL] [Abstract][Full Text] [Related]
16. Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant gamma-tocotrienol.
Kumar KS; Raghavan M; Hieber K; Ege C; Mog S; Parra N; Hildabrand A; Singh V; Srinivasan V; Toles R; Karikari P; Petrovics G; Seed T; Srivastava S; Papas A
Life Sci; 2006 Mar; 78(18):2099-104. PubMed ID: 16413038
[TBL] [Abstract][Full Text] [Related]
17. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
18. Improved metastatic animal model of human prostate carcinoma using surgical orthotopic implantation (SOI).
Chang XH; Fu YW; Na WL; Wang J; Sun H; Cai L
Anticancer Res; 1999; 19(5B):4199-202. PubMed ID: 10628375
[TBL] [Abstract][Full Text] [Related]
19. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
[TBL] [Abstract][Full Text] [Related]
20. [Effects of anti-gene and antisense therapeutics on human prostate cancer xenograft in nude mice].
Zhang Y; Ma Y; Lu HP; Zhou XF; Xie Y; Gao JH; Liang CS
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2073-6. PubMed ID: 19080439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
